PRESS RELEASE Key NHS cannabis project to kick off A key project developing a flexible health economics analysis tool to
HAVING secured up to £26.7m of funding from a FTSE-250 listed investment fund, Glass Pharms, the UK-based medical cannabis cultivation
GLASS Pharms has agreed a £22.5m funding deal to build the UK mainland’s first, high-THC, commercial cultivation facility for over
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
